MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease

NCT02226510 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Left Ventricular Hypertrophy
Insulin Resistance
Coronary Artery Disease
PreDiabetes

Interventions

DRUG: Metformin XL
DRUG: Placebo

Sponsor

University of Dundee